MCKMcKesson Corporation

$115B

Q1 2023 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$67.2B+7.1% YoY

Gross Profit

$2.9B4.4% margin

Operating Income

$1.1B1.6% margin

Net Income

$768M1.1% margin

EPS (Diluted)

$5.26

QoQ Revenue Growth

+1.6%

Cash Flow

Operating Cash Flow

-$941M

Free Cash Flow

-$1.0B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$62.3B

Total Liabilities

$63.8B

Stockholders' Equity

-$2.0B

Cash & Equivalents

$2.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67.2B	$62.7B	+7.1%
Gross Profit	$2.9B	$2.9B	+1.5%
Operating Income	$1.1B	$800M	+33.0%
Net Income	$768M	$486M	+58.0%

Revenue Segments

U.S. Pharmaceutical Segment

$56.9B85%

International Segment

$6.5B10%

Medical-Surgical Solutions Segment

$2.6B4%

Prescription Technology Solutions

$1.1B2%

MCK Q1 2023 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena